Open AccessPrevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate
Author(s) -
ShangIan Tee
Publication year - 2011
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2011.354
Subject(s) - medicine , placebo , femoral neck , osteoporosis , alendronic acid , glucocorticoid , adverse effect , bone density , osteopenia , surgery , bone mineral , randomized controlled trial , gastroenterology , urology , pathology , alternative medicine
To evaluate the efficacy and safety of oral alendronate sodium therapy once daily in preventing glucocorticoid-induced bone loss in patients with immunobullous skin diseases treated with long-term glucocorticoid therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom